Dynavax Announces Exercise of Option to Reserve Additional CpG 1018 to Produce 40 Million Doses of Valneva's Inactivated, Adjuvanted COVID-19 Vaccine Candidate for the UK GovernmentPRNewsWire • 02/01/21
Dynavax and CEPI Announce $99 Million in Funding for CpG 1018 Adjuvant Manufacturing to Support the Global COVID-19 ResponsePRNewsWire • 02/01/21
Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine CandidatePRNewsWire • 02/01/21
Medigen Vaccine Biologics COVID-19 Vaccine Adjuvanted with Dynavax's CpG 1018 Announces First Participant Dosed in Phase 2 Clinical Trial in TaiwanPRNewsWire • 01/25/21
Serum Institute Of India And Dynavax Announce First Participants Dosed In The Phase 1/2 Clinical Trial For A COVID-19 VaccinePRNewsWire • 12/23/20
European CHMP Adopts Positive Opinion for HEPLISAV-B®, Dynavax's Two Dose Adult Hepatitis B Adjuvanted VaccinePRNewsWire • 12/10/20
Clover Biopharmaceuticals Announces Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine CandidatesBusiness Wire • 12/04/20
Biological E. Limited Starts Phase I/II Clinical Trial of its COVID-19 Vaccine CandidatePRNewsWire • 11/16/20
Dynavax Technologies (DVAX) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/05/20
Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/05/20
Dynavax Technologies (DVAX) Dips More Than Broader Markets: What You Should KnowZacks Investment Research • 10/27/20
Clover Biopharmaceuticals Announces Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine CandidateBusiness Wire • 09/25/20
Dynavax Announces Appointment of New Board Member and Planned Retirement of Chief Financial OfficerPRNewsWire • 09/24/20
Valneva and Dynavax Announce Commercial Supply Agreement for Inactivated, Adjuvanted COVID-19 VaccineGlobeNewsWire • 09/14/20